Phase
Condition
N/ATreatment
SYB PDO Thread
MINT lift®
Clinical Study ID
Ages 19-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Those desiring temporary improvement of central facial nasolabial folds and having aWrinkle Severity Rating Scale (WSRS) score of 3 or 4.
Individuals willing to discontinue all dermatological procedures or treatments,including wrinkle improvement in the central facial nasolabial fold, throughout theduration of this clinical trial.
Exclusion
Exclusion Criteria:
Individuals who need to take anticoagulants from 2 weeks before the application ofthe clinical trial medical device to 2 weeks after (low-dose aspirin 100mg, maximum 300mg/day, is allowed).
Those who need to take Vitamin E supplements, NSAIDs, or collagen supplements from 1week before the application of the clinical trial medical device to 1 week after.
Individuals with a history of bleeding disorders, either past or present.
Those who have received treatments such as deep chemical peels, skin rejuvenationprocedures, plastic surgery (including Botox injections), wrinkle improvement, oracne scar treatment on the face within 24 weeks from the screening date.
Study Design
Connect with a study center
Kyung Hee University Hospital
Seoul,
Korea, Republic ofActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.